Table of Contents
•The global Contract Research Organization (CRO) market was $ x billion in 2014 and is expected to reach $ x billion in 2019, growing at a robust CAGR (2014–2019) of x %.
•The penetration of the global CRO market stood at x % in 2014 against the potential outsourcing market, providing a huge opportunity for CRO companies to increase their market share.
•The share of services, such as Data Management, Biostatistics, Health Economic Outcome Research (HEOR), and Central Labs is expected to grow at a double-digit rate in the next x – years.
•Geographic outsourcing to lower-cost locations is likely to result in lesser margins but increased volume share in the short term. However, with increased capacity and scale, companies are expected to improve their margins during the rest of the forecast period.
•The volume of outsourcing to emerging markets is expected to increase significantly. However, North America will retain a large portion of the high-value business.
•Specialized services, such as eClinical Trial Solutions, Adaptive Trial Designs, and Health Economic Outcomes Research, are expected to transform the way clinical trials are performed today.
•Phase III is the highest revenue-generating segment with $ x billion revenue in 2014 and accounted for x % of total CRO outsourcing market.
•Globally, Pharmacovigilance is expected to witness highest growth rate during the forecast period with a CAGR (2014–2019) of x %, closely followed by Phase IV with a CAGR (2014–2019) of x %.
•APAC region will experience the highest growth rate in forecast period, outpacing other regions, with a CAGR of x % between 2014–2019.
•Data management in the APAC region is expected to witness the highest growth rate of x % compared to all other segments.
•The top ten CRO companies contributed to x % of the total CRO market in 2014. Quintiles leads the market with x % of global market share, followed by Covance ( x %), Parexel ( x %), PRA International ( x %), and PPD ( x %).
•M&A will continue to drive consolidation in the CRO industry. Larger companies will continue to expand through acquisitions. LabCorp’s acquisition of Covance, the second largest CRO company, is an example of the former’s aggressive expansion strategy.
•Rest of World (ROW)
•This research service analyses the global clinical trials and research outsourcing (CRO) market.
•It provides revenue forecasts for CROs globally by phase, therapeutic type, and region.
•The research study addresses major issues and challenges, unmet needs, and emerging trends in the market. In addition, it outlines market drivers and restraints and R&D trends.
Key Questions This Study Will Answer
How will contract research outsourcing help in drug development by saving time and cost for manufacturers?
What is the impact of the market growth in different regions?
Who are the dominant market participants in the CRO market and their market share contribution?
What are the key market trends observed toward expansion of contract research organizations in drug development across key therapeutic areas?
Do the products/services offered today meet customer needs or is additional development needed?
What are the key segments to look out for and what are the key trends in the market?
Get Industry Insights. Simply.
Talk to Veronica
+1 718 514 2762
This 2017 module has 138 pages and 67 tables and figures Worldwide hyperscale data center markets implement cloud computing with shared resource and the aim, more or less achieved of providing foolproof ...
The Need to Defend Against Zero-day and Ransomware Attacks Driving the Adoption of NAMA Solutions The network-based advanced malware analysis solutions market in Asia-Pacific (APAC) continued to maintain ...
Actionable Strategies to Remain Relevant Amidst the Cloudy Landscape New analysis from Frost & Sullivan’s Digital Transformation program titled Growth Opportunities in the Global Contact Center Systems ...